A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Part
publicerad i: British Journal of Cancer
utgivningsår: 1993-12-01
språk: engelska
huvudämne: lungcancer, Ifosfamid, Metotrexat, etoposide
Refererar artiklar 14
Datum
Titel
Artikel - wd:Q35977520